Gene · 407053
Papers3,090
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 3,090
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Secreted miR-210-3p, miR-183-5p and miR-96-5p reduce sensitivity to docetaxel in prostate cancer cells. | Cell Death Discov | 2023 | 38065937 | PubTator, text mining | PubMed |
| Exosomal miR-182 derived from bone marrow mesenchymal stem cells drives carfilzomib resistance of multiple myeloma cells by targeting SOX6. | J Orthop Surg Res | 2023 | 38062424 | PubTator, text mining | PubMed |
| miR-423 sponged by lncRNA NORHA inhibits granulosa cell apoptosis. | J Anim Sci Biotechnol | 2023 | 38053184 | PubTator, text mining | PubMed |
| The direct transfer approach for transcellular drug delivery. | Drug Deliv | 2023 | 38037327 | PubTator, text mining | PubMed |
| FBXW7 and human tumors: mechanisms of drug resistance and potential therapeutic strategies. | Front Pharmacol | 2023 | 38027013 | PubTator, text mining | PubMed |
| The Clinical Significance of MicroRNAs in Colorectal Cancer Signaling Pathways: A Review. | Glob Med Genet | 2023 | 38025193 | PubTator, text mining | PubMed |
| Identifying the potential miRNA biomarkers based on multi-view networks and reinforcement learning for diseases. | Brief Bioinform | 2023 | 38018913 | PubTator, text mining | PubMed |
| Research progress of N6-methyladenosine in colorectal cancer: A review. | Medicine (Baltimore) | 2023 | 38013272 | PubTator, text mining | PubMed |
| Accurate phenotypic classification and exome sequencing allow identification of novel genes and variants associated with adult-onset hearing loss. | PLoS Genet | 2023 | 38011198 | PubTator, text mining | PubMed |
| The Role of Exosome-Derived microRNA on Lung Cancer Metastasis Progression. | Biomolecules | 2023 | 38002256 | PubTator, text mining | PubMed |
| Unveiling a Biomarker Signature of Meningioma: The Need for a Panel of Genomic, Epigenetic, Proteomic, and RNA Biomarkers to Advance Diagnosis and Prognosis. | Cancers (Basel) | 2023 | 38001599 | PubTator, text mining | PubMed |
| Small molecule regulators of microRNAs identified by high-throughput screen coupled with high-throughput sequencing. | Nat Commun | 2023 | 37989753 | PubTator, text mining | PubMed |
| In silico analysis of prognostic and diagnostic significance of target genes from prostate cancer cell lines derived exomicroRNAs. | Cancer Cell Int | 2023 | 37978493 | PubTator, text mining | PubMed |
| Retraction Note: LncRNA NDRG1 aggravates osteosarcoma progression and regulates the PI3K/AKT pathway by sponging miR-96-5p. | BMC Cancer | 2023 | 37978354 | PubTator, text mining | PubMed |
| The emerging role of m6A modification of non-coding RNA in gastrointestinal cancers: a comprehensive review. | Front Cell Dev Biol | 2023 | 37965577 | PubTator, text mining | PubMed |
| Progress in the study of FOXO3a interacting with microRNA to regulate tumourigenesis development. | Front Oncol | 2023 | 37965449 | PubTator, text mining | PubMed |
| Prognostic value of CASC15 and LINC01600 as competitive endogenous RNAs in lung adenocarcinoma: An observational study. | Medicine (Baltimore) | 2023 | 37960753 | PubTator, text mining | PubMed |
| The Arising Role of Extracellular Vesicles in Cholangiocarcinoma: A Rundown of the Current Knowledge Regarding Diagnostic and Therapeutic Approaches. | Int J Mol Sci | 2023 | 37958547 | PubTator, text mining | PubMed |
| Role of Non-Coding RNAs in Hepatocellular Carcinoma Progression: From Classic to Novel Clinicopathogenetic Implications. | Cancers (Basel) | 2023 | 37958352 | PubTator, text mining | PubMed |
| MiRNAs and Their Role in Venous Thromboembolic Complications. | Diagnostics (Basel) | 2023 | 37958279 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/407053/papers?page=6